First Trust Advisors LP Harmony Biosciences Holdings, Inc. Transaction History

First Trust Advisors LP

$108 Billion
Q1 2025

A detailed history of First Trust Advisors LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 100,197 shares of HRMY stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,197

Previous 169,409 40.85%

Holding current value

$3.2 Million

Previous $5.83 Million 42.96%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$32.18 - $40.46 $2.23 Million - $2.8 Million	-69,212 Reduced 40.85%	100,197 $3.33 Million
Q4 2024 Feb 13, 2025	BUY	$31.86 - $41.49 $3.88 Million - $5.05 Million	121,810 Added 255.91%	169,409 $5.83 Million
Q3 2024 Nov 13, 2024	SELL	$30.0 - $39.95 $654,690 - $871,828	-21,823 Reduced 31.44%	47,599 $1.9 Million
Q2 2024 Aug 13, 2024	BUY	$28.81 - $33.01 $1.65 Million - $1.89 Million	57,327 Added 473.97%	69,422 $2.09 Million
Q1 2024 May 13, 2024	SELL	$29.93 - $35.06 $692,939 - $811,709	-23,152 Reduced 65.69%	12,095 $406,000
Q4 2023 Feb 13, 2024	BUY	$19.2 - $33.78 $475,833 - $837,169	24,783 Added 236.84%	35,247 $1.14 Million
Q3 2023 Nov 13, 2023	BUY	$31.89 - $39.03 $333,696 - $408,409	10,464 New	10,464 $342,000
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $3.62 Million - $6.34 Million	-117,579 Reduced 57.71%	86,174 $2.81 Million
Q4 2022 Feb 09, 2023	BUY	$45.4 - $60.91 $587,203 - $787,809	12,934 Added 6.78%	203,753 $11.2 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $941,050 - $1.24 Million	22,374 Added 13.28%	190,819 $8.45 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $52.15 $202,749 - $315,246	6,045 Added 3.72%	168,445 $8.22 Million
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $1.58 Million - $2.44 Million	47,775 Added 41.68%	162,400 $7.9 Million
Q4 2021 Feb 08, 2022	BUY	$34.09 - $43.91 $3.91 Million - $5.03 Million	114,625 New	114,625 $4.89 Million
Q4 2020 Feb 02, 2021	SELL	$31.74 - $51.34 $1.94 Million - $3.13 Million	-61,030 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$30.96 - $44.39 $1.89 Million - $2.71 Million	61,030 New	61,030 $2.07 Million

Others Institutions Holding HRMY

# of Institutions

278

Shares Held

44.8M

Call Options Held

130K

Put Options Held

46.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.89B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Harmony Biosciences Holdings, Inc. Transaction History